July 2017

Features

Smoking-Cessation Services in Community Pharmacies

Tobacco use is the leading preventable cause of death in the United States.

The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness

Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.

Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP

Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.

Consult Your Pharmacist

Proton Pump Inhibitors: Considerations With Long-Term Use

Prescription proton pump inhibitors (PPIs) have proven to be effective and safe in managing gastroesophageal reflux disease (GERD); however, these products are sometimes overused and misused.

Contemporary Compounding

Ethambutol Hydrochloride Compounded Oral Suspension USP (100 mg/mL)

This preparation should be used not as the sole antituberculous drug, but rather in conjunction with one or more others.

Editorial

Cessation’s Secret Weapon

Armed with the latest treatment modalities, pharmacists are key in reducing smokers’ ranks.

TrendWatch

Epidemiology of Chronic Lung Diseases

According to the American Lung Association, more than 35 million Americans have a preventable chronic lung disease.